The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajiv Dinesh Gandhi
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rajiv Dinesh Gandhi acquired 1,111 equity shares of Hester Biosciences Ltd from Dr. Bhupendra Vithaldas Gandhi via an off-market gift transaction on 4 September 2025. This is an inter-se transfer within the promoter family, with no impact on the overall promoter and promoter group holding, which remains unchanged at 53.73% (45,70,944 shares). Rajiv Gandhi's individual stake moved marginally from 10.47% to 10.48%, while Dr. Bhupendra Gandhi's stake shifted from 4.69% to 4.68%. The total equity share capital of the company is INR 8,50,68,650, divided into 85,06,865 shares of INR 10 each.
This is a routine internal reshuffling among promoter family members via a gift and has no material impact on the company's ownership structure or shareholders. The stock price is unlikely to be affected since overall promoter control and voting power remain identical.